Skip to main content

Financial news

The newsroom

Headlines from the Federal Reserve, ECB, Bank of Japan, Bank of England, SEC EDGAR, the White House and the DOJ. Context notes are written automatically by software from each headline, not by an editor. They are neutral and information-only, Kresmion publishes no buy or sell recommendations.

Public RSS feeds · refreshed every 30 minutes

  • SEC EDGAR•filings
    8-K - Sonoma Pharmaceuticals, Inc. (0001367083) (Filer)

    Automated noteSonoma Pharmaceuticals, Inc. filed a Form 8-K indicating that it has submitted certain matters to a vote of its security holders, as disclosed in Item 5.07 of the filing.

  • SEC EDGAR•filings
    8-K - IMPACT BIOMEDICAL INC. (0001834105) (Filer)

    Automated noteImpact Biomedical Inc. filed a Form 8-K on September 17, 2026, containing a Regulation FD disclosure and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - HEARTLAND EXPRESS INC (0000799233) (Filer)

    Automated noteHeartland Express Inc. filed a Form 8-K on September 17, 2026, reporting Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits) (Accession No. 0000799233-26-000043, 149 KB).

  • SEC EDGAR•filings
    8-K - Nordicus Partners Corp (0001011060) (Filer)

    Automated noteNordicus Partners Corp filed an 8-K reporting entry into a material definitive agreement, the creation of a direct financial obligation/off-balance-sheet arrangement, unregistered sales of equity securities, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K/A - Brand Engagement Network Inc. (0001838163) (Filer)

    Automated noteBrand Engagement Network Inc. filed a Form 8-K amendment on September 17, 2026, providing Item 9.01 financial statements and exhibits (accession 0001493152-26-042965, 829 KB).

  • SEC EDGAR•filings
    8-K - Ernexa Therapeutics Inc. (0000748592) (Filer)

    Automated noteErnexa Therapeutics Inc. filed a Form 8-K on September 16 2026 (Accession No. 0001493152-26-042963), containing a Regulation FD disclosure and the company's financial statements and related exhibits.

  • SEC EDGAR•filings
    8-K - FG Nexus Inc. (0001591890) (Filer)

    Automated noteFG Nexus Inc. filed a Form 8-K on September 16, 2026, containing a Regulation FD disclosure and financial statements with related exhibits.

  • SEC EDGAR•filings
    8-K - Aperture AC (0002093524) (Filer)

    Automated noteAperture AC filed a Form 8-K on September 16 2026, disclosing entry into a material definitive agreement and providing its financial statements and related exhibits.

  • SEC EDGAR•filings
    8-K - Apollo Commercial Real Estate Finance, Inc. (0001467760) (Filer)

    Automated noteApollo Commercial Real Estate Finance, Inc. filed a Form 8-K with the SEC on September 16 2026 (Accession No. 0001193125-26-393256), reporting an Item 8.01 “Other Events” disclosure.

  • SEC EDGAR•filings
    8-K - Tenon Medical, Inc. (0001560293) (Filer)

    Automated noteTenon Medical, Inc. filed an 8-K on September 16, 2026, reporting entry into a material definitive agreement, unregistered sales of equity securities, other events, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - CID Holdco, Inc. (0002033770) (Filer)

    Automated noteCID Holdco, Inc. filed a Form 8-K on September 16, 2026, reporting entry into a material definitive agreement, unregistered sales of equity securities, other events, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - BATTALION OIL CORP (0001282648) (Filer)

    Automated noteBattalion Oil Corp filed a Form 8-K on September 16, 2026, disclosing a notice of delisting or failure to meet a continued listing rule and indicating a transfer of its listing.

  • SEC EDGAR•filings
    8-K - ESSENTIAL PROPERTIES REALTY TRUST, INC. (0001728951) (Filer)

    Automated noteEssential Properties Realty Trust filed an 8-K reporting entry into and termination of material definitive agreements, creation of a direct financial obligation or off-balance-sheet arrangement, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - Matinas BioPharma Holdings, Inc. (0001582554) (Filer)

    Automated noteMatinas BioPharma Holdings, Inc. filed a Form 8-K with the SEC on September 16, 2026, reporting an Item 8.01 “Other Events” disclosure.

  • SEC EDGAR•filings
    8-K - Clene Inc. (0001822791) (Filer)

    Automated noteClene Inc. filed a Form 8-K on September 16, 2026, reporting entry into a material definitive agreement, other events, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - Tevogen Inc. (0001860871) (Filer)

    Automated noteTevogen Inc. filed a Form 8-K on September 16, 2026, reporting departures, elections, appointments, and compensatory arrangements for certain officers, and included its financial statements and related exhibits.

  • SEC EDGAR•filings
    8-K - DataMeds AI, Inc. (0002030763) (Filer)

    Automated noteDataMeds AI, Inc. filed an 8-K on September 16, 2026 reporting a material definitive agreement, a direct financial obligation/off-balance-sheet arrangement, unregistered equity sales, a Regulation FD disclosure, and related financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - Nuburu, Inc. (0001814215) (Filer)

    Automated noteNuburu, Inc. filed an 8-K on September 16, 2026 indicating it does not rely on previously issued financial statements, audit report, or completed interim review.

  • SEC EDGAR•filings
    8-K - WOLFSPEED, INC. (0000895419) (Filer)

    Automated noteWolfspeed, Inc. filed a Form 8-K on September 16, 2026, reporting other events and providing its financial statements and related exhibits.

  • SEC EDGAR•filings
    8-K - Churchill Capital Corp XIII (0002114229) (Filer)

    Automated noteChurchill Capital Corp XIII filed a Form 8-K on September 16, 2026, reporting other events under Item 8.01 and including financial statements and exhibits under Item 9.01.

  • SEC EDGAR•filings
    8-K - ADIAL PHARMACEUTICALS, INC. (0001513525) (Filer)

    Automated noteAdial Pharmaceuticals filed a Form 8-K on September 16, 2026, reporting entry into a material definitive agreement, other events, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - AMERICAN BATTERY TECHNOLOGY Co (0001576873) (Filer)

    Automated noteAmerican Battery Technology Co filed an 8-K on September 16, 2026, including Item 2.02 covering results of operations and financial condition and Item 9.01 containing financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - ChronoScale Holdings Corp (0001549084) (Filer)

    Automated noteChronoScale Holdings Corp filed a Form 8-K on September 16, 2026, reporting entry into a material definitive agreement and including its financial statements and related exhibits.

  • SEC EDGAR•filings
    8-K - SurgePays, Inc. (0001392694) (Filer)

    Automated noteSurgePays, Inc. filed a Form 8-K reporting a change in its certifying public accountant.

  • SEC EDGAR•filings
    8-K - Bone Biologics Corp (0001419554) (Filer)

    Automated noteBone Biologics Corp filed an 8-K on September 16, 2026, reporting a notice of delisting or failure to satisfy a continued listing rule and a transfer of its listing.

  • SEC EDGAR•filings
    8-K/A - RTB Digital, Inc. (0001419275) (Filer)

    Automated noteRTB Digital, Inc. filed a Form 8-K amendment on September 16, 2026, including its financial statements and related exhibits as required under Item 9.01.

  • SEC EDGAR•filings
    8-K - NORWOOD FINANCIAL CORP (0001013272) (Filer)

    Automated noteNorwood Financial Corp filed a Form 8-K on September 16, 2026, reporting Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).

  • SEC EDGAR•filings
    8-K - Celanese Corp (0001306830) (Filer)

    Automated noteCelanese Corp filed a Form 8-K on September 16, 2026, reporting departures, elections and appointments of directors or certain officers, related compensatory arrangements, and providing its financial statements and accompanying exhibits.

  • SEC EDGAR•filings
    8-K - TuHURA Biosciences, Inc./NV (0001498382) (Filer)

    Automated noteTuHURA Biosciences, Inc. filed an 8-K on September 16, 2026 reporting departures, elections, appointments and compensatory arrangements of certain officers, and providing financial statements and related exhibits.

  • SEC EDGAR•filings
    8-K - HINES GLOBAL INCOME TRUST, INC. (0001585101) (Filer)

    Automated noteHines Global Income Trust, Inc. filed a Form 8-K with the SEC on September 16, 2026, containing Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).